Table 3.
Study | Follow- up Period (years) |
Cohort Size (baseline free of CHD) |
Mean Age (years) |
Women (%) |
Minorities (%) |
Nonfatal CHD Measure |
CHD Death Measure |
---|---|---|---|---|---|---|---|
Brown 2010 | 15 | 3767 (2717) | 67 | 68.8 | 63.4 | serum CK-MB > 0.3 ng/ml or serum troponin >0.3 mcg/L | NDI Data |
Ahto 2007 | 12 | 1196 (715) | 71 | 59 | 0 | N/A | Official Death Registry |
Mendes De Leon 1998 | 9 | 2488 (2391) | 72 | 60.5 | 0 | discharge diagnosis, serum CK with increase > 4% in MB fraction | Death Certificates |
CHD=coronary heart disease, CK-MB=creatine kinase myocardial band isoenzyme, NDI=National Death Index.
Follow-up period approaching 10 years, sample size ≥ 1,000 participants, and mean age ≥ 60 years.